In responding to a global pandemic, how do we balance the competing aims of preserving our health and minimizing disruptions to our lives and livelihoods? This remains the central question to every relevant policy debate six months in. This week, however, this debate has come to an unsettling new stage: a conversation over whether our testing itself has been conducted in an overly cautious way.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source
Andrew Egger is White House correspondent for The Bulwark. He previously covered politics for The Dispatch and The Weekly Standard.
